中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

48 records (took 0.03 seconds)

    Systems and methods employing a bite block insert for positioning and stabilizing external instruments deployed within the body
    21.
    发明申请
    Systems and methods employing a bite block insert for positioning and stabilizing external instruments deployed within the body 审中-公开
    使用咬入块插入件来定位和稳定部署在体内的外部器械的系统和方法

    公开(公告)号：US20070118080A1

    公开(公告)日：2007-05-24

    申请号：US11650076

    申请日：2007-01-05

    Applicant: Scott West ,  David Utley ,  John Gaiser

    Inventor： Scott West ,  David Utley ,  John Gaiser

    IPC: A61M5/32

    CPC classification number: A61B18/1485 ,  A61B1/00154 ,  A61M16/0493 ,  A61M25/02 ,  A61M29/02 ,  A61M2025/024 ,  Y10S128/06 ,  Y10S128/26

    Abstract: Systems and methods are provided for positioning and stabilizing an external instrument during insertion of the instrument through the oral cavity (e.g., insertion of a catheter through the oral cavity and into the esophagus or cardia for treatment of gastroesophageal reflux disease (GERD)). The systems and methods provide a gripping tool for association with a bite block, capable of selectively moving between an open position in which the instrument may be inserted or instrument is held in a fixed position.

    Abstract translation: 提供了系统和方法，用于在将器械插入口腔（例如，将导管穿过口腔插入食管或贲门以治疗胃食管反流病（GERD））期间定位和稳定外部器械。 这些系统和方法提供了一种用于与咬合块相关联的夹持工具，其能够选择性地在可以插入仪器的打开位置或仪器被保持在固定位置之间移动。

    Sphincter treatment apparatus
    23.
    发明申请
    Sphincter treatment apparatus 审中-公开
    括约肌治疗仪

    公开(公告)号：US20070032788A1

    公开(公告)日：2007-02-08

    申请号：US11580543

    申请日：2006-10-13

    Applicant: Stuart Edwards ,  John Gaiser ,  David Utley ,  Jay Qin

    Inventor： Stuart Edwards ,  John Gaiser ,  David Utley ,  Jay Qin

    IPC: A61B18/14

    Abstract: An apparatus treats tissue at or near a sphincter. The apparatus has an elongated member having at least one lumen including an inflation lumen, and a basket assembly including a first and a second arm. An inflatable member is coupled to the inflation lumen and has a deployed and a non-deployed state. In the deployed state, the inflatable member expands the basket assembly into contact with tissue. At least one of the first and second arms of the basket assembly has a fluid lumen having an aperture for conveying a fluid from the basket assembly. A source of fluid is coupled to the fluid lumen for conveyance of fluid through the aperture. The fluid can be, e.g., an electrolytic solution, and/or an anti-infection agent, and/or an echogenic media, and/or a steroid, and/or an anesthetic, and/or a medicament, and/or a tissue cooling agent. The source can be a drug delivery device.

    Abstract translation: 装置处理括约肌处或附近的组织。 该装置具有细长构件，其具有包括充气腔的至少一个腔，以及包括第一臂和第二臂的篮组件。 可膨胀构件联接到膨胀腔并具有展开和非展开状态。 在展开状态下，可膨胀构件将篮组件膨胀成与组织接触。 篮组件的第一和第二臂中的至少一个具有流体腔，其具有用于从篮组件输送流体的孔。 流体源耦合到流体腔，用于输送流体通过该孔。 流体可以是例如电解溶液和/或抗感染剂和/或回声介质，和/或类固醇，和/或麻醉剂，和/或药物，和/或组织 冷却剂。 来源可以是药物递送装置。

    Intraoral aversion devices and methods
    27.
    发明申请
    Intraoral aversion devices and methods 有权
    口腔内厌恶装置和方法

    公开(公告)号：US20050263160A1

    公开(公告)日：2005-12-01

    申请号：US10943379

    申请日：2004-09-17

    Applicant: David Utley ,  Jack Utley ,  Peter Keith ,  Michael Berman ,  Robert Atkinson

    Inventor： David Utley ,  Jack Utley ,  Peter Keith ,  Michael Berman ,  Robert Atkinson

    IPC: A24F47/00

    CPC classification number: A24F47/00

    Abstract: An intraoral aversion device to assist a user in quitting an undesirable behavior such as tobacco smoking, tobacco chewing, use of snuff, illicit drug use, excessive alcohol consumption, excessive food consumption, and/or other undesirable activity facilitated via the mouth. The aversion device may be wholly or partially configured to be disposed in the user's mouth, for example. The aversion device may include a detector and a output device, wherein the detector is configured to detect a parameter indicative of the user engaging in the habit or undesirable activity. If (and only if) the detector detects such a parameter, the output device delivers a negative stimulus to the user, thus providing negative feedback and creating an incentive for the user to limit if not eliminate the undesirable activity.

    Abstract translation: 口腔厌恶装置，用于帮助用户戒除诸如吸烟，烟草咀嚼，使用鼻烟，非法药物使用，过度饮酒，过度饮食消耗等不良行为和/或通过口促进的其他不良活动等不良行为。 例如，厌恶装置可以被全部或部分地配置为设置在使用者的口中。 厌恶装置可以包括检测器和输出装置，其中检测器被配置为检测指示用户参与习惯或不期望的活动的参数。 如果（且仅当）检测器检测到这样的参数，则输出设备向用户传送负激励，从而提供负反馈并且为用户创造激励以限制如果不消除不期望的活动。

    Method for treating fecal incontinence
    29.
    发明授权
    Method for treating fecal incontinence 有权
    治疗大便失禁的方法

    公开(公告)号：US07699844B2

    公开(公告)日：2010-04-20

    申请号：US11446771

    申请日：2006-06-05

    Applicant: David Utley ,  Scott West ,  John Gaiser ,  Rachel Croft

    Inventor： David Utley ,  Scott West ,  John Gaiser ,  Rachel Croft

    IPC: A61B18/18

    CPC classification number: A61B18/1477 ,  A61B1/31 ,  A61B18/1485 ,  A61B2018/00267 ,  A61B2018/00482 ,  A61B2018/00553 ,  A61B2018/00797 ,  A61B2018/0091 ,  A61B2018/00916 ,  A61B2018/046 ,  A61B2090/3782 ,  A61B2218/007

    Abstract: A sphincter tissue region is treated using a support structure sized for advancement into the anal canal. At least one electrode is carried by the structure. A mechanism is coupled to the electrode to move the electrode between a first position retracted in the support structure and a second position extended from the support structure through surface tissue to penetrate a subsurface tissue region at or near a sphincter in the anal canal. A cable is coupled to the electrode to conduct energy for application by the electrode to form a lesion in the subsurface tissue region.

    Abstract translation: 括约肌组织区域使用尺寸适合进入肛管的支撑结构来治疗。 该结构承载至少一个电极。 机构耦合到电极以在缩回到支撑结构中的第一位置和从支撑结构延伸穿过表面组织的第二位置之间移动电极，以穿透肛管内的括约肌处或附近的下表面组织区域。 电缆耦合到电极以传导电极施加的能量，以在地下组织区域中形成病变。

    Systems and methods for applying a selected treatment agent into contact with tissue
    30.
    发明申请
    Systems and methods for applying a selected treatment agent into contact with tissue 有权
    将选定的处理剂施用于与组织接触的系统和方法

    公开(公告)号：US20080033374A1

    公开(公告)日：2008-02-07

    申请号：US11906457

    申请日：2007-10-02

    Applicant: David Utley ,  John Gaiser ,  Rachel Croft

    Inventor： David Utley ,  John Gaiser ,  Rachel Croft

    IPC: A61M25/06 ,  A61M25/09

    CPC classification number: A61B18/1492 ,  A61B18/1477 ,  A61B2018/00214 ,  A61B2018/00232 ,  A61B2018/00553 ,  A61B2018/00797 ,  A61B2018/00815 ,  A61B2018/1425 ,  A61M25/0084

    Abstract: Systems and methods that treat disorders of the gastrointestinal tract by applying one or more treatment agents to tissue at or near the region where abnormal neurological symptoms or abnormal tissue conditions exist. The treatment agent is selected to either disrupt the abnormal nerve pathways and/or to alleviate the abnormal tissue conditions. The treatment agent can include at least one cytokine and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or as a neoadjuvent or adjuvant treatment modality.

    Abstract translation: 通过将一种或多种治疗剂施用于存在异常神经症状或异常组织病状的区域处或附近的组织来治疗胃肠道疾病的系统和方法。 选择治疗剂以破坏异常神经通路和/或减轻异常组织状况。 治疗剂可以包括至少一种细胞因子和/或至少一种香草酸化合物以引起所需的组织应答。 系统和方法可以用作主要治疗方式，或作为新辅助治疗方式。

Patent Agency Ranking